• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4,5-trisubstituted oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles 2,4,5-trisubstituted oxazoles

Recent Advances in the Application of (2,4-dimethyl-1,3-oxazol-5-yl)methanol (CAS: 214553-55-6) in Chemical Biology and Pharmaceutical Research

The compound (2,4-dimethyl-1,3-oxazol-5-yl)methanol (CAS: 214553-55-6) has recently garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications as a key synthetic intermediate and its potential biological activities. This research briefing provides an updated overview of the latest advancements related to this compound, focusing on its synthetic utility, pharmacological properties, and emerging applications in drug discovery.

Recent synthetic chemistry studies have demonstrated the effectiveness of (2,4-dimethyl-1,3-oxazol-5-yl)methanol as a building block for heterocyclic compounds. A 2023 publication in the Journal of Medicinal Chemistry reported its use in the synthesis of novel kinase inhibitors, where the oxazole moiety was found to enhance binding affinity through specific hydrogen bond interactions with target proteins. The hydroxymethyl group at the 5-position proved particularly valuable for further derivatization, allowing for the creation of diverse molecular architectures.

In pharmacological research, several studies have explored the biological activities of derivatives containing the (2,4-dimethyl-1,3-oxazol-5-yl)methanol scaffold. A recent screening study published in Bioorganic & Medicinal Chemistry Letters identified promising antimicrobial activity against drug-resistant bacterial strains, with minimum inhibitory concentrations (MICs) in the range of 2-8 μg/mL for certain derivatives. The mechanism of action appears to involve interference with bacterial cell wall biosynthesis, though detailed studies are ongoing.

The compound has also shown potential in central nervous system (CNS) drug development. Research from 2024 indicates that appropriately modified derivatives can cross the blood-brain barrier and exhibit neuroprotective effects in preclinical models of neurodegenerative diseases. The oxazole ring system contributes to both the desired pharmacokinetic properties and the pharmacodynamic activity, making this scaffold particularly interesting for CNS-targeted therapeutics.

From a chemical biology perspective, (2,4-dimethyl-1,3-oxazol-5-yl)methanol derivatives have been employed as fluorescent probes and molecular tags. A recent study in Chemical Communications demonstrated their utility in live-cell imaging applications, where the oxazole core provided excellent photostability and the hydroxymethyl group allowed for specific conjugation to biomolecules of interest.

In conclusion, (2,4-dimethyl-1,3-oxazol-5-yl)methanol (CAS: 214553-55-6) continues to be a valuable compound in pharmaceutical research, with recent studies expanding its applications across multiple therapeutic areas. The compound's synthetic versatility, combined with emerging biological activities of its derivatives, suggests it will remain an important scaffold in drug discovery efforts. Future research directions likely include further exploration of its structure-activity relationships and optimization of derivatives for specific therapeutic targets.

• 20662-84-4(2,4,5-Trimethyloxazole)
• 137267-30-2((2-ethyl-4-methyl-1,3-oxazol-5-yl)methanol)
• 69062-86-8(2,4-Dimethyloxazole-5-carbaldehyde)
• 45515-23-9((4-Methyloxazol-5-yl)methanol)
• 137267-50-6(5-Oxazolemethanol, 4-ethyl-2-methyl-)
• 33318-74-0(Oxazole, 5-ethyl-2,4-dimethyl-)
• 2510-37-4(dimethyl-1,3-oxazole-5-carboxylic acid)
• 92901-94-5((2,5-dimethyl-1,3-oxazol-4-yl)methanol)
• 92901-88-7(2,5-dimethyl-1,3-oxazole-4-carbaldehyde)
• 53833-30-0(2-Ethyl-4,5-dimethyloxazole)